Katharine Bar is an Infectious Disease physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
8 Penn Tower
Philadelphia, PA 191044206
Telephone
215-662-6932Registry record last updated 31 Oct 2011.
Clinical trials
- Observational PIC Destination Cohort
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20259 payments$11,600openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year20252 payments
- ViiV Healthcare CompanyProgram year202410 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
47.8%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor16.2%Triumeq100%Part D<11 patientsProtease Inhibitor11%Darunavir60%Ritonavir40%Part D<11 patients+ 4 more classes in this area
Cardiovascular
30.2%Statin11.3%Atorvastatin Calcium68%Rosuvastatin Calcium32%Part D<11 patientsCalcium channel blocker10.7%Amlodipine Besylate100%Part D<11 patients+ 2 more classes in this area
Nervous system
14.3%Opioid Agonist6.6%Oxycodone Hcl50%Oxycodone-Acetaminophen50%Part D<11 patientsGabapentinoids4.4%Gabapentin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1
University of Pennsylvania
FY2026$1,721,127U01AI169767 - Selective inhibition of T cell trafficking to brain in acute SHIV.D infected RM will prevent CNS seeding, persistence, and neuropathogenesis
University of Pennsylvania
FY2026$1,217,055R01MH143137 - Therapeutic vaccination to boost autologous neutralizing antibodies for ART free HIV Control
University of Pennsylvania
FY2026$881,967R37AI195421
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”